Recent news on Fondaparinux

New Marketing and Manufacturing Partner Appointed for Synthetic ...  -  Apr 25, 2007
PR Newswire (press release),About Synthetic Heparin (Fondaparinux). Alchemia has used its proprietary carbohydrate technology to develop a generic version of the antithrombotic drug

New Marketing and Manufacturing Partner Appointed for Synthetic ...  -  26 Apr 2007
PR Newswire (press release),About Synthetic Heparin (Fondaparinux). Alchemia has used its proprietary carbohydrate technology to develop a generic version of the antithrombotic drug

GlaxoSmithKline Receives Japanese Approval For Two Major New ...  -  Apr 23, 2007
Medical News Today (press release),Diskus (salmeterol and fluticasone proprionate combination) and Arixtra (fondaparinux sodium) from the Ministry of Health, Labour and Welfare in Japan.

Japanese nod for GSK's Seretide/Advair and Arixtra  -  Apr 19, 2007
Pharma Times (subscription),GSK's anti-thrombotic Arixtra (fondaparinux sodium) has been cleared as a once-daily subcutaneous injection of 1.5mg and 2.5mg for the prevention of venous

GlaxoSmithKline Receives Approvable Letter For New Indications For ...  -  Feb 5, 2007
Medical News Today (press release),The FDA priority review was completed in six months. GSK will continue to work with the FDA to provide the additional information requested to complete the

GlaxoSmithKline Receives Approvable Letter for New Indications for ...  -  Feb 2, 2007
PR Newswire (press release),...(FDA) has issued an approvable letter for the once-daily anticoagulant, ARIXTRA (fondaparinux sodium) Injection, for the treatment of patients with

GlaxoSmithKline Receives Approvable Letter for New Indications for ...  -  Feb 2, 2007
PR Newswire (press release),ARIXTRA (fondaparinux sodium) Injection, for the treatment of patients with -- Unstable angina or non-ST segment elevation myocardial infarction

Approvable Letter Issued for New Arixtra Indications  -  Feb 5, 2007
Facts and Comparisons,The FDA has issued an approvable letter to GlaxoSmithKline’s Arixtra (fondaparinux sodium) injection for the treatment of patients with unstable angina or

Optimal Timing for Use of Glycoprotein IIb/IIIa Inhibitors in ...  -  Feb 13, 2007
Journal of American Medical Association (subscription),19 ACUITY (bivalirudin vs unfractionated heparin/low-molecular-weight heparin), 3 OASIS (fondaparinux vs enoxaparin), 20 and other trials,

GSK gets non-approvable FDA letter for Arixtra indications  -  Feb 5, 2007
Pharma Times (subscription),The drug major has only received an approvable letter from the agency for Arixtra (fondaparinux sodium) for the treatment of patients with acute coronary

(PRN) - Concreteideas.com: A New Resource for Decorative Concrete ...  -  Feb 2, 2007
Bolsamania.com,...(PRN) - GlaxoSmithKline Receives Approvable Letter for New Indications for ARIXTRA(R) (Fondaparinux Sodium) Injection ... [+]

Fondaparinux significantly reduces risk of death for myocardial ...  -  Dec 19, 2006
Xagena.it,The study included 12092 patients with STEMI from 447 hospitals in 41 countries who were randomized to receive Fondaparinux 2.5 mg once daily for up to 8

Fondaparinux significantly reduces risk of death for myocardial ...  -  Dec 19, 2006
Xagena.it,The study included 12092 patients with STEMI from 447 hospitals in 41 countries who were randomized to receive Fondaparinux 2.5 mg once daily for up to 8

Fondaparinux in Patients With ST-Segment Elevation Myocardial ...  Oct 31, 2006
In Reply: Dr Hartig and colleagues speculate that the trend toward lower bleeding with fondaparinux may be due to inadvertent unblinding and consequent ... -Journal of American Medical Association (subscription), Fondaparinux in Patients With ST-Segment Elevation Myocardial ...  Oct 31, 2006
To the Editor: In their study of the effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction ... -Journal of American Medical Association (subscription), Fondaparinux in Patients With ST-Segment Elevation Myocardial ...  Oct 31, 2006
1 showed improved survival and a tendency toward decreased severe bleeding in patients treated with the factor Xa inhibitor fondaparinux compared with ... -Journal of American Medical Association (subscription), Fondaparinux in Patients With ST-Segment Elevation Myocardial ...  Oct 31, 2006
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA. ... -Journal of American Medical Association (subscription), OASIS-5 and -6 combined give more data on fondaparinux  Sep 8, 2006
Barcelona, Spain - New data taken from the combined results of the OASIS-5 and OASIS-6 trials show that the antithrombin fondaparinux is superior to ... -TheHeart.Org

Preventing bleeding is key to the treatment of acute coronary ...  Sep 5, 2006
Recent trials have shown that two anticoagulant drugs - bivalirudin and fondaparinux - can both reduce the risk of bleeding in some situations. ... -News-Medical.net

STEEPLE supports safety of enoxaparin vs UFH in elective PCI, but ...  Sep 8, 2006
...practice. Emerging findings for fondaparinux, including updates presented at the WCC, are only adding another layer of complexity. ... -TheHeart.Org

New observations from OASIS-6/EXTRACT-TIMI 25  -  Nov 20, 2006
TheHeart.Org,Chicago, IL - Results of many different subgroup analyses from the OASIS-6 and EXTRACT-TIMI 25 studies of the antithrombin agents fondaparinux and

ACUITY published: Bivalirudin—an alternative to heparin plus IIb ...  -  Nov 22, 2006
TheHeart.Org,He concluded: "The bottom line for me is that unfractionated heparin, low-molecular-weight heparin, fondaparinux, and bivalirudin all appear to have a role

To intervene or not? Still no consensus on best approach for ACS  Jul 28, 2006
...might make them redundant. "And what role will new antithrombotics such as fondaparinux or bivalirudin play?". Another much-debated ... -TheHeart.Org

New Trials of Antithrombotic Therapy for ACS -- ACC 2006  Jul 21, 2006
OASIS-6 compared fondaparinux with either placebo or UFH. ... The trial also compared fondaparinux to 2 control arms: (1) placebo and (2) UFH. ... -Medscape (subscription)

Abraxis BioScience: A SPARC for Explosive Growth? (ABBI)  Jul 19, 2006
Together with a number of anti-infective (injectibles) in the FDA product pipeline are generic Arixtra (an anticoagulant called Fondaparinux—derived from ... -Seeking Alpha



Director, Cardiac Care Unit  May 11, 2006
The recently published OASIS-5 trial of approximately 20 000 patients comparing fondaparinux to enoxaparin further refines antithrombin strategy by ... - TheHeart.Org



Arixtra Effective and Well Tolerated in Acutely Ill Medical ...  Feb 14, 2006
LONDON, UK, and PHILADELPHIA, PA -- February 14, 2006 -- Results from the ARTEMIS study of Arixtra® (fondaparinux sodium) demonstrated that treatment with the ... - DG News

ARIXTRA(R) Administered the Morning After Orthopedic Surgery ...  Feb 3, 2006
3 /PRNewswire/ -- Results from a new study of ARIXTRA(R) (fondaparinux sodium) called FLEXTRA (Flexibility in Administration of Fondaparinux for Prevention of ... - International News Service,

GSK's Arixtra Shows Promise in Acutely Ill Patients  Feb 14, 2006
Results from the study, named Artemis, demonstrated that treatment with Arixtra (fondaparinux sodium) reduced patients' risk of overall venous thromboembolism ... - International News Service,

Arixtra® administered the morning after orthopedic surgery ...  Feb 3, 2006
Philadelphia, PA, February 3, 2006–Results from a new study of Arixtra® (fondaparinux sodium) called FLEXTRA (Flexibility in Administration of Fondaparinux ... - WebWire,

New Oral Anticoagulants Show Promise  Feb 14, 2006
One such factor Xa inhibitor, fondaparinux, is currently approved for use in the United States, but like low-molecular-weight heparin, it must be given by ... - Journal of American Medical Association (subscription),

Arixtra halves blood clot risk, study shows  Feb 14, 2006
UK drugmaker GlaxoSmithKline's blood-thinner Arixtra (fondaparinux sodium) can cut patients' risk of forming venous blood clots by nearly half, according to a ... - Pharma Times (subscription),

Arixtra Administered the Morning After Orthopedic Surgery ...  Feb 3, 2006
PHILADELPHIA, PA -- February 3, 2006 -- Results from a new study of Arixtra(R) (fondaparinux sodium) called FLEXTRA (Flexibility in Administration of ... - DG News

ARIXTRA(R) Administered the Morning After Orthopedic Surgery ...  Feb 3, 2006
3 /PRNewswire/ -- Results from a new study of ARIXTRA(R) (fondaparinux sodium) called FLEXTRA (Flexibility in Administration of Fondaparinux for Prevention of ... - International News Service

Arixtra® administered the morning after orthopedic surgery ...  Feb 3, 2006
Philadelphia, PA, February 3, 2006–Results from a new study of Arixtra® (fondaparinux sodium) called FLEXTRA (Flexibility in Administration of Fondaparinux ... - WebWire

ARIXTRA(R) Administered the Morning After Orthopedic Surgery ...  Feb 3, 2006
3 /PRNewswire/ -- Results from a new study of ARIXTRA® (fondaparinux sodium) called FLEXTRA (Flexibility in Administration of Fondaparinux for Prevention of ... - Yahoo! News

ARIXTRA drug for venous thromboembolism  Feb 4, 2006
ARIXTRA drug which is called as FLEXTRA (Flexibility in Administration of Fondaparinux for Prevention of Symptomatic Venous Thromboembolism in Orthopaedic ... - MedIndia

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional